Element Capital Management’s AC Immune ACIU Stock Holding History

Element Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-33,102	Closed	-$167K	–	242
2019 Q1	$167K	Buy	+33,102	New	+$211K	0.01%	773

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Element Capital Management's ACIU Position: Q2 2019 in Review

Element Capital Management sold out of AC Immune (ACIU) in Q2 2019, closing a stake of 33,102 shares — an estimated $167K sold.

Element Capital Management first reported a position in ACIU in Q1 2019 and held it in 1 quarter. The position peaked at $167K in Q1 2019. 40 funds tracked by Wall St. Rank hold ACIU as of Q2 2019.

Element Capital Management reported no remaining AC Immune position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 33,102 AC Immune shares in Q2 2019, an estimated $167K.
Element Capital Management first reported a position in AC Immune in Q1 2019 and held it in 1 quarter.
Element Capital Management's AC Immune position peaked at $167K in Q1 2019.
40 funds tracked by Wall St. Rank held AC Immune as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.